APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 46 filers reported holding APPLIED GENETIC TECHNOL CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -83.3% | 4,080 | -47.1% | 0.00% | – |
| Q2 2022 | $6,000 | -76.0% | 7,712 | -67.5% | 0.00% | – |
| Q1 2022 | $25,000 | +400.0% | 23,744 | +842.6% | 0.00% | – |
| Q4 2021 | $5,000 | -95.3% | 2,519 | -92.8% | 0.00% | – |
| Q3 2021 | $106,000 | -31.6% | 35,083 | -11.6% | 0.00% | – |
| Q2 2021 | $155,000 | -58.3% | 39,698 | -45.9% | 0.00% | -100.0% |
| Q1 2021 | $372,000 | +217.9% | 73,407 | +155.8% | 0.00% | – |
| Q4 2020 | $117,000 | -26.4% | 28,693 | -12.6% | 0.00% | – |
| Q3 2020 | $159,000 | +287.8% | 32,811 | +346.1% | 0.00% | – |
| Q2 2020 | $41,000 | – | 7,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,455,904 | $7,075,000 | 2.04% |
| DAFNA Capital Management LLC | 1,095,139 | $5,322,000 | 1.73% |
| Portolan Capital Management | 1,301,075 | $6,323,000 | 0.72% |
| Sofinnova Investments, Inc. | 825,071 | $4,010,000 | 0.30% |
| Ikarian Capital, LLC | 545,884 | $2,654,000 | 0.19% |
| 683 Capital Management, LLC | 364,299 | $1,770,000 | 0.13% |
| Gyon Technologies Capital Management, LP | 18,653 | $91,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 336,900 | $1,637,000 | 0.07% |
| HighVista Strategies LLC | 15,200 | $74,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 176,411 | $857,000 | 0.04% |